Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted therapies in the treatment of non-small cell lung cancer].

Bulletin du cancer - 1 Mar 2008

De Grève Jacques, Decoster Lore, Van Meerbeek Jan, Vermeij Joanna, Teugels Erik, Schallier Denis

Abstract excerpt

New targeted treatments offer an important opening towards the improvement of the results in the treatment of lung cancer. Currently two types of therapeutic targets are developed successfully in the treatment of advanced non-small cell lung cancer: tumour angiogenesis and growth factor receptors. Therapeutic drugs are small molecules inhibitors and the monoclonal antibodies. Bevacizumab is a monoclonal antibody...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bevacizumab

Share to Cetuximab

Share to Erlotinib Hydrochloride

Share to Gefitinib

Share to Neovascularization, Pathologic

Share to Vascular Endothelial Growth Factor Receptor-1

Source

Identifiers

PMID: 18390417
DOI: 10.1684/bdc.2008.0591

Genes

EGFR
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted therapies in the treatment of non-small cell lung cancer].PMID 18390417Read ↗

[New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis].Semantic proximity Read ↗

[Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?].Semantic proximity Read ↗

[Targeted therapies and non-small cell carcinomas : novelties].Semantic proximity Read ↗

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].Semantic proximity Read ↗

[News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)].Semantic proximity Read ↗

[Current status of EGFR/ErbB inhibitors in non-small cell lung carcinoma].Semantic proximity Read ↗

[Biomarkers and targeted therapies in non-small cell lung cancer: present and future treatments].Semantic proximity Read ↗

[Changes in the diagnostic and therapeutic strategies of non-small cell lung cancer].Semantic proximity Read ↗

Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.Semantic proximity Read ↗

Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.Semantic proximity Read ↗

[New biological treatments for lung cancer].Semantic proximity Read ↗

[Small-molecule tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.